Evoke (LON:EVOK) Trading Down 18.7% – Here’s What Happened

Shares of Evoke plc (LON:EVOKGet Free Report) dropped 18.7% on Thursday . The stock traded as low as GBX 56 ($0.72) and last traded at GBX 58.05 ($0.75). Approximately 55,595,465 shares changed hands during trading, an increase of 1,853% from the average daily volume of 2,847,325 shares. The stock had previously closed at GBX 71.40 ($0.92).

Wall Street Analysts Forecast Growth

Several brokerages have issued reports on EVOK. Berenberg Bank lowered their price target on Evoke from GBX 130 ($1.67) to GBX 90 ($1.16) and set a “buy” rating for the company in a report on Wednesday, December 4th. Jefferies Financial Group reaffirmed a “buy” rating and issued a GBX 140 ($1.80) price target on shares of Evoke in a research note on Monday, December 16th.

Get Our Latest Stock Analysis on EVOK

Evoke Stock Down 4.4 %

The stock has a fifty day moving average of GBX 69.75 and a 200-day moving average of GBX 63.69. The firm has a market capitalization of £244.85 million, a P/E ratio of -1.37 and a beta of 0.84.

Evoke (LON:EVOKGet Free Report) last issued its quarterly earnings results on Wednesday, March 26th. The company reported GBX (6.40) (($0.08)) earnings per share for the quarter. Evoke had a negative return on equity of 517.98% and a negative net margin of 8.50%. Sell-side analysts predict that Evoke plc will post 12.7648305 EPS for the current fiscal year.

Insider Activity

In related news, insider Andrea Gisle Joosen purchased 14,572 shares of Evoke stock in a transaction that occurred on Tuesday, January 28th. The stock was purchased at an average cost of GBX 70 ($0.90) per share, with a total value of £10,200.40 ($13,133.00). 27.00% of the stock is owned by corporate insiders.

Evoke Company Profile

(Get Free Report)

See Also

Receive News & Ratings for Evoke Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Evoke and related companies with MarketBeat.com's FREE daily email newsletter.